Xyris Pharmaceuticals Private Limited
About Xyris Pharmaceuticals Private Limited
Data last updated:
Xyris Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the paper and paper products segment of the paper and packaging sector. It was incorporated on 01 March 2024.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U21009MH2024PTC420418.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Jose Carlos and Shrinidhi Anant Mulgund.
Its last annual general meeting (AGM) was held on 31 December 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
Company details
Contact details
Xyris Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra.
- Registered AddressPlot 93 Flat 504 Floor No.5, Gorai Skylark Chsl Gorai2, Mumbai, Maharashtra, India – 400091
- IndustryPaper, Paper & Paper Products, Manufacturing
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Xyris Pharmaceuticals Private Limited
FY 2025 filings availableFinancial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ||
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ||
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | ||
| Net Profit Margin | ||
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Xyris Pharmaceuticals Private Limited, buy the company report.
Board of directors of Xyris Pharmaceuticals Private Limited
Xyris Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jose Carlos | Director | 01 Mar 2024 | 2 Years 8 Months | Current |
| Shrinidhi Anant Mulgund | Director | 01 Mar 2024 | 2 Years 8 Months | Current |
Legal cases
No court or tribunal cases involving Xyris Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Xyris Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Xyris Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Xyris Pharmaceuticals Private Limited has 2 board changes on record since 2024: 2 appointments. The latest: Jose Carlos was appointed as Director on 01 Mar 2024.
Frequently asked questions
Xyris Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in paper and paper products, within the paper industry. It was incorporated on 01 March 2024 (2+ years old) and is registered under CIN U21009MH2024PTC420418.
Xyris Pharmaceuticals has 2 current directors:
- Jose Carlos - Director
- Shrinidhi Anant Mulgund - Director
The latest financial statements of Xyris Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 31 December 2025. Year-wise statements from FY 2024 are in the company report.
The CIN (Corporate Identification Number) of Xyris Pharmaceuticals is U21009MH2024PTC420418. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Xyris Pharmaceuticals was incorporated on 01 March 2024, making it 2+ years old. It is registered with the Registrar of Companies, Mumbai.
Jose Carlos was appointed as Director on 01 Mar 2024. Shrinidhi Anant Mulgund was appointed as Director on 01 Mar 2024.
The registered office of Xyris Pharmaceuticals is at Plot 93 Flat 504 Floor No.5, Gorai Skylark Chsl Gorai2, Mumbai, Maharashtra, India – 400091.
Xyris Pharmaceuticals operates in the paper industry, in the paper and paper products segment.
Xyris Pharmaceuticals can be reached at its registered office: Plot 93 Flat 504 Floor No.5, Gorai Skylark Chsl Gorai2, Mumbai, Maharashtra, India – 400091.
Xyris Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Mumbai.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
